Biomarker for early cancer detection. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Prostate Breast Nipple Aspirate Fluid Rectum Saliva Neoplastic Stem Cells Neoplastic Cells, Circulating Tumor Cells, Cultured

Organisms1

Diseases43

Neoplasms Breast Neoplasms Stomach Neoplasms Prostatic Neoplasms Precancerous Conditions Colorectal Neoplasms Esophageal Neoplasms Adenocarcinoma Colonic Neoplasms Barrett Esophagus Gastrointestinal Neoplasms Ovarian Neoplasms Lung Neoplasms Urinary Bladder Neoplasms Carcinoma Pancreatic Neoplasms Uterine Cervical Neoplasms Carcinoma, Squamous Cell Mouth Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Disease Progression Prostatic Intraepithelial Neoplasia Genetic Predisposition to Disease Prostatic Hyperplasia Carcinoma, Non-Small-Cell Lung Carcinoma in Situ Carcinoma, Intraductal, Noninfiltrating Neoplasm Recurrence, Local Carcinoma, Transitional Cell Cell Transformation, Neoplastic Rectal Neoplasms Liver Neoplasms Endometrial Neoplasms Head and Neck Neoplasms Neoplastic Cells, Circulating Neoplasms, Glandular and Epithelial Skin Neoplasms Bone Neoplasms Neoplasms, Hormone-Dependent Disease Models, Animal Neovascularization, Pathologic Carcinoma, Small Cell

Chemicals and Drugs35

Tumor Markers, Biological Neodymium Prostate-Specific Antigen Biological Markers Neoplasm Proteins Antigens, Neoplasm DNA, Neoplasm CA-125 Antigen RNA, Messenger MicroRNAs Contrast Media Cancer Vaccines Antineoplastic Agents Carcinoembryonic Antigen Receptors, Estrogen Receptor, erbB-2 Radiopharmaceuticals DNA Primers Antibodies, Monoclonal RNA, Small Interfering Tumor Suppressor Protein p53 Fluorescent Dyes Fluorouracil Receptors, Progesterone Tamoxifen Cisplatin Antineoplastic Agents, Hormonal Receptor, Epidermal Growth Factor Anticarcinogenic Agents Antineoplastic Agents, Phytogenic Tumor Suppressor Proteins Paclitaxel Reagent Kits, Diagnostic Carcinogens Biomarkers, Pharmacological

Analytical, Diagnostic and Therapeutic Techniques and Equipment120

Early Detection of Cancer Sensitivity and Specificity Mass Screening Mammography Early Diagnosis Molecular Imaging Endoscopy, Gastrointestinal Biopsy Gastroscopy Neoplasm Staging Reproducibility of Results Prognosis Digital Rectal Examination ROC Curve Colonoscopy Predictive Value of Tests Biopsy, Large-Core Needle Polymerase Chain Reaction Ultrasonography, Mammary Prospective Studies Biopsy, Needle Limit of Detection False Positive Reactions Magnetic Resonance Imaging, Interventional Image-Guided Biopsy Retrospective Studies Gene Expression Profiling Palpation Radiographic Image Interpretation, Computer-Assisted Follow-Up Studies Risk Assessment Tomography Enzyme-Linked Immunosorbent Assay Diagnostic Imaging Area Under Curve Survival Rate Case-Control Studies Registries Protein Array Analysis Image Interpretation, Computer-Assisted Reverse Transcriptase Polymerase Chain Reaction Risk Factors Immunoassay Breast Self-Examination False Negative Reactions Tomography, Optical Cohort Studies Magnetic Resonance Imaging Tumor Burden Neoplasm Grading Radiographic Image Enhancement Image Enhancement Logistic Models Physical Examination Cystoscopy Immunohistochemistry Survival Analysis Multivariate Analysis Plethysmography, Impedance Subtraction Technique Incidence Prostatectomy Diagnosis, Computer-Assisted Oligonucleotide Array Sequence Analysis Positron-Emission Tomography Blotting, Western Reference Standards Risk Antineoplastic Combined Chemotherapy Protocols Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Xenograft Model Antitumor Assays Immunoenzyme Techniques Reference Values Pilot Projects Thermography Questionnaires Models, Statistical Disease-Free Survival Equipment Design Tomography, X-Ray Computed Observer Variation Cytodiagnosis Neoplasm Transplantation Kaplan-Meier Estimate Odds Ratio Phantoms, Imaging Tissue Array Analysis Imaging, Three-Dimensional Real-Time Polymerase Chain Reaction Combined Modality Therapy Prevalence Transplantation, Heterologous Mass Spectrometry Chemotherapy, Adjuvant Clinical Trials as Topic Ultrasonography Models, Biological Biosensing Techniques Vaginal Smears Treatment Outcome Flow Cytometry Spectrum Analysis Evaluation Studies as Topic Molecular Targeted Therapy Ultrasonography, Interventional Chromatography, High Pressure Liquid Molecular Diagnostic Techniques Chromatography, Liquid Sequence Analysis, DNA Drug Screening Assays, Antitumor DNA Mutational Analysis Disease Models, Animal Scattering, Radiation Specimen Handling Transfection Reagent Kits, Diagnostic Bacteriological Techniques In Situ Hybridization, Fluorescence SEER Program Confidence Intervals

Psychiatry and Psychology2

Breast Self-Examination Smoking

Phenomena and Processes38

Sensitivity and Specificity DNA Methylation Gene Expression Regulation, Neoplastic Algorithms Area Under Curve Time Factors Optical Phenomena Mutation Genetic Predisposition to Disease Microwaves Drug Resistance, Neoplasm Epigenesis, Genetic Risk Genes, Tumor Suppressor Genotype Base Sequence CpG Islands Odds Ratio Cell Survival Dose-Response Relationship, Drug Down-Regulation Cell Proliferation Polymorphism, Genetic Up-Regulation Cell Movement Promoter Regions, Genetic Apoptosis Gene Expression Phenotype Cell Division Genes, BRCA1 Cell Cycle Scattering, Radiation RNA Interference Transfection Gene Silencing Diet Genes, Neoplasm

Disciplines and Occupations4

Proteomics Immunohistochemistry Radiology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science17

Algorithms Radiographic Image Interpretation, Computer-Assisted Survival Rate Registries Image Interpretation, Computer-Assisted Radiographic Image Enhancement Image Enhancement Incidence Diagnosis, Computer-Assisted Molecular Sequence Data Base Sequence Questionnaires Image Processing, Computer-Assisted Pattern Recognition, Automated Imaging, Three-Dimensional Prevalence SEER Program

Named Groups1

Health Care38

Sensitivity and Specificity Mass Screening Reproducibility of Results ROC Curve Predictive Value of Tests Prospective Studies Limit of Detection Retrospective Studies Follow-Up Studies Risk Assessment Area Under Curve Survival Rate Case-Control Studies Age Factors Registries Risk Factors Cohort Studies Logistic Models Survival Analysis Multivariate Analysis Incidence National Cancer Institute (U.S.)Risk Pilot Projects Questionnaires Models, Statistical Disease-Free Survival Observer Variation Kaplan-Meier Estimate Odds Ratio Prevalence Clinical Trials as Topic Treatment Outcome Evaluation Studies as Topic Referral and Consultation SEER Program Cost-Benefit Analysis Confidence Intervals

Geographicals3

United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Early Detection of Cancer Neoplasms Tumor Markers, Biological Sensitivity and Specificity Breast Neoplasms Mass Screening Stomach Neoplasms Prostatic Neoplasms Mammography Precancerous Conditions Neodymium Early Diagnosis Molecular Imaging Endoscopy, Gastrointestinal Biopsy Gastroscopy Prostate-Specific Antigen Colorectal Neoplasms Neoplasm Staging Esophageal Neoplasms Reproducibility of Results Adenocarcinoma DNA Methylation Colonic Neoplasms Prognosis Digital Rectal Examination Barrett Esophagus Biological Markers ROC Curve Cell Line, Tumor Colonoscopy Gastrointestinal Neoplasms Prostate Ovarian Neoplasms Lung Neoplasms Predictive Value of Tests Biopsy, Large-Core Needle Polymerase Chain Reaction Urinary Bladder Neoplasms Gene Expression Regulation, Neoplastic Neoplasm Proteins Ultrasonography, Mammary Breast Prospective Studies Nipple Aspirate Fluid Carcinoma Biopsy, Needle Limit of Detection False Positive Reactions Magnetic Resonance Imaging, Interventional Image-Guided Biopsy Retrospective Studies Pancreatic Neoplasms Gene Expression Profiling Algorithms Palpation Mice, Nude United States Radiographic Image Interpretation, Computer-Assisted Uterine Cervical Neoplasms Proteomics Follow-Up Studies Risk Assessment Tomography Carcinoma, Squamous Cell Mouth Neoplasms Antigens, Neoplasm Enzyme-Linked Immunosorbent Assay Diagnostic Imaging Neoplasm Metastasis Area Under Curve DNA, Neoplasm Survival Rate Case-Control Studies Age Factors Registries Neoplasm Invasiveness CA-125 Antigen RNA, Messenger Protein Array Analysis Image Interpretation, Computer-Assisted Reverse Transcriptase Polymerase Chain Reaction MicroRNAs Time Factors Risk Factors Immunoassay Breast Self-Examination False Negative Reactions Tomography, Optical Cohort Studies Magnetic Resonance Imaging Tumor Burden Optical Phenomena Disease Progression Neoplasm Grading Contrast Media Radiographic Image Enhancement Image Enhancement Logistic Models Physical Examination

No FAQ available that match "biomarker for early cancer detection"